OK Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	305.79	314.47	277.46	323.03	596.42	599.85
Trading Asset Securities	12.18	12.59	13.04	42.31	40.23	44.78
Cash & Short-Term Investments	317.98	327.06	290.5	365.34	636.64	644.64
Cash Growth	1.00%	12.58%	-20.48%	-42.61%	-1.24%	13.75%
Accounts Receivable	445.87	383.12	560.19	439.36	383.27	376.79
Other Receivables	5.55	26.72	28.31	49.23	26.21	28.11
Receivables	451.42	409.84	588.5	488.59	409.47	404.9
Inventory	444.71	456	530.54	394.05	422.95	375.64
Prepaid Expenses	52.78	-	-	64.47	49.47	57.76
Other Current Assets	4.86	56.36	63.13	4.91	7.98	6.06
Total Current Assets	1,272	1,249	1,473	1,317	1,527	1,489
Property, Plant & Equipment	2,041	2,028	1,627	865.71	874.73	659.4
Long-Term Investments	24.26	23.36	22.24	358.92	458.52	482.25
Goodwill	-	353.52	353.52	23.63	23.63	29.63
Other Intangible Assets	461.68	111.56	124.97	1.79	8.95	16.12
Long-Term Deferred Tax Assets	66.71	72	62.34	57.11	51.15	44.28
Other Long-Term Assets	23.09	11.41	32.39	442.84	117.71	92.09
Total Assets	3,888	3,849	3,695	3,067	3,061	2,813
Accounts Payable	121.89	140.42	258.32	203.8	244.63	240.4
Accrued Expenses	-	38.86	44.19	21.31	51.33	26.03
Short-Term Debt	215	295	305	155.03	185.73	187.04
Current Portion of Long-Term Debt	-	10.19	55.46	79.62	205.64	142.8
Current Portion of Leases	23.79	10.74	3.82	3.19	3.12	2.26
Current Income Taxes Payable	6.13	2.24	11.87	-	33.76	-
Current Unearned Revenue	25.02	23.04	48.44	90.32	67.83	53.87
Other Current Liabilities	119.52	27.13	17.67	24.86	36.14	48.16
Total Current Liabilities	511.35	547.6	744.76	578.13	828.18	700.55
Long-Term Debt	678.51	606.46	322	91.94	382.97	401.76
Long-Term Leases	78.95	90.76	33.77	2.17	3.17	-
Long-Term Deferred Tax Liabilities	25.55	25.17	27.85	-	0.43	-
Other Long-Term Liabilities	3.32	3.32	0.02	0.02	0.02	7.43
Total Liabilities	1,298	1,273	1,128	672.26	1,215	1,110
Common Stock	1,448	1,448	1,471	1,458	995.02	949.34
Additional Paid-In Capital	-	-	-	922.29	600.99	562.02
Retained Earnings	275.61	263.7	247.53	158.06	268.07	203.67
Comprehensive Income & Other	802.62	801.34	773.95	-140.19	-19.46	-10.52
Total Common Equity	2,526	2,513	2,492	2,398	1,845	1,705
Minority Interest	64.06	62.93	74.84	-2.76	1.79	-1.5
Shareholders' Equity	2,590	2,576	2,567	2,395	1,846	1,703
Total Liabilities & Equity	3,888	3,849	3,695	3,067	3,061	2,813
Total Debt	996.26	1,013	720.05	331.95	780.63	733.86
Net Cash (Debt)	-678.28	-686.09	-429.55	33.39	-143.98	-89.22
Net Cash Per Share	-4.68	-4.70	-2.93	0.26	-1.11	-0.75
Filing Date Shares Outstanding	141.93	141.12	143.06	145.77	109.66	104.63
Total Common Shares Outstanding	141.93	141.12	143.06	145.77	109.66	104.63
Working Capital	760.39	701.65	727.9	739.22	698.33	788.44
Book Value Per Share	17.80	17.81	17.42	16.45	16.82	16.29
Tangible Book Value	2,065	2,048	2,014	2,372	1,812	1,659
Tangible Book Value Per Share	14.55	14.51	14.08	16.28	16.52	15.85
Land	-	417.61	417.61	417.61	417.61	185.4
Buildings	-	345.47	345.47	345.04	344.72	343.3
Machinery	-	342.51	321.15	320.7	286.11	190.59
Construction In Progress	-	1,124	791.9	20.51	16.01	93.21